← Insider buys
ADAP

Adaptimmune Therapeutics Plc · HEALTHCARE

Director and 10% owner David M Mott bought $2.4M of Adaptimmune Therapeutics Plc

Bought$2,417,847
$1.91Price
1,268,508Shares
+2%Stake

What ADAP did for a copier

Prices for ADAP after this filing aren't in yet.

David M Mott's record

9 other buys with 3 months of prices since 2016: on average +19.6% against the S&P 500, and 7 of 9 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Wed, Mar 21. Filed Fri, Mar 23, 2:32 PM ET, during the session. Not investment advice.